{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:32:06Z","timestamp":1793277126372,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0108037"],"award-info":[{"award-number":["JP19fk0108037"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The reliable diagnosis of human T-cell leukemia virus type 1 (HTLV-1) infection is important, particularly as it can be vertically transmitted by breast feeding mothers to their infants. However, current diagnosis in Japan requires a confirmatory western blot (WB) test after screening\/primary testing for HTLV-1 antibodies, but this test often gives indeterminate results. Thus, this collaborative study evaluated the reliability of diagnostic assays for HTLV-1 infection, including a WB-based one, along with line immunoassay (LIA) as an alternative to WB for confirmatory testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Using peripheral blood samples from blood donors and pregnant women previously serologically screened and subjected to WB analysis, we analyzed the performances of 10 HTLV-1 antibody assay kits commercially available in Japan. No marked differences in the performances of eight of the screening kits were apparent. However, LIA determined most of the WB-indeterminate samples to be conclusively positive or negative (an 88.0% detection rate). When we also compared the sensitivity to HTLV-1 envelope gp21 with that of other antigens by LIA, the sensitivity to gp21 was the strongest. When we also compared the sensitivity to envelope gp46 by LIA with that of WB, LIA showed stronger sensitivity to gp46 than WB did. These findings indicate that LIA is an alternative confirmatory test to WB analysis without gp21. Therefore, we established a novel diagnostic test algorithm for HTLV-1 infection in Japan, including both the performance of a confirmatory test where LIA replaced WB on primary test-reactive samples and an additional decision based on a standardized nucleic acid detection step (polymerase chain reaction, PCR) on the confirmatory test-indeterminate samples. The final assessment of the clinical usefulness of this algorithm involved performing WB analysis, LIA, and\/or PCR in parallel for confirmatory testing of known reactive samples serologically screened at clinical laboratories. Consequently, LIA followed by PCR (LIA\/PCR), but neither WB\/PCR nor PCR\/LIA, was found to be the most reliable diagnostic algorithm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Because the above results show that our novel algorithm is clinically useful, we propose that it is recommended for solving the aforementioned WB-associated reliability issues and for providing a more rapid and precise diagnosis of HTLV-1 infection.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12977-020-00534-0","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T11:03:02Z","timestamp":1598266982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan"],"prefix":"10.1186","volume":"17","author":[{"given":"Kazu","family":"Okuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Kuramitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokuni","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gohzoh","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Sobata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Satake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonori","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Masuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Umeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Uchimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Ryang","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisato","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Okajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Tezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Ikebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahoko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"issue":"12","key":"534_CR1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"534_CR2","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78(10):6476\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"534_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","volume":"137","author":"L Willems","year":"2017","unstructured":"Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, et al. Reducing the global burden of HTLV-1 infection: an agenda for research and action. Antiviral Res. 2017;137:41\u20138.","journal-title":"Antiviral Res"},{"issue":"3","key":"534_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481\u201392.","journal-title":"Blood"},{"issue":"8488","key":"534_CR5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1(8488):1031\u20132.","journal-title":"Lancet"},{"issue":"8801","key":"534_CR6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0140-6736(92)90699-4","volume":"339","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K. HTLV-I and uveitis. Lancet. 1992;339(8801):1110.","journal-title":"Lancet"},{"issue":"11","key":"534_CR7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1586\/1744666X.2014.966690","volume":"10","author":"F Martin","year":"2014","unstructured":"Martin F, Taylor GP, Jacobson S. Inflammatory manifestations of HTLV-1 and their therapeutic options. Expert Rev Clin Immunol. 2014;10(11):1531\u201346.","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"534_CR8","first-page":"481","volume":"76","author":"K Yamanouchi","year":"1985","unstructured":"Yamanouchi K, Kinoshita K, Moriuchi R, Katamine S, Amagasaki T, Ikeda S, et al. Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn J Cancer Res. 1985;76(6):481\u20137.","journal-title":"Jpn J Cancer Res"},{"issue":"12","key":"534_CR9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1349-7006.1993.tb02832.x","volume":"84","author":"H Take","year":"1993","unstructured":"Take H, Umemoto M, Kusuhara K, Kuraya K. Transmission routes of HTLV-I: an analysis of 66 families. Jpn J Cancer Res. 1993;84(12):1265\u20137.","journal-title":"Jpn J Cancer Res"},{"issue":"5","key":"534_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1423-0410.1984.tb00083.x","volume":"46","author":"K Okochi","year":"1984","unstructured":"Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 1984;46(5):245\u201353.","journal-title":"Vox Sang"},{"issue":"2","key":"534_CR11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmv.23181","volume":"84","author":"M Satake","year":"2012","unstructured":"Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84(2):327\u201335.","journal-title":"J Med Virol"},{"issue":"11","key":"534_CR12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S1473-3099(16)30252-3","volume":"16","author":"M Satake","year":"2016","unstructured":"Satake M, Iwanaga M, Sagara Y, Watanabe T, Okuma K, Hamaguchi I. Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis. Lancet Infect Dis. 2016;16(11):1246\u201354.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"534_CR13","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1128\/jcm.30.10.2555-2559.1992","volume":"30","author":"H Miyakoshi","year":"1992","unstructured":"Miyakoshi H, Sugimoto M, Igarashi H, Honda H, Fujino R, Mizukoshi M. Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay. J Clin Microbiol. 1992;30(10):2555\u20139.","journal-title":"J Clin Microbiol"},{"key":"534_CR14","unstructured":"Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from western blot assays for HIV-1, HIV-2, and HTLV-I\/HTLV-II. Wkly Epidemiol Rec. 1990;65(37):281\u20133."},{"issue":"6","key":"534_CR15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1537-2995.1990.30690333477.x","volume":"30","author":"S Kwok","year":"1990","unstructured":"Kwok S, Lipka JJ, McKinney N, Kellogg DE, Poiesz B, Foung SK, et al. Low incidence of HTLV infections in random blood donors with indeterminate western blot patterns. Transfusion. 1990;30(6):491\u20134.","journal-title":"Transfusion"},{"issue":"10","key":"534_CR16","first-page":"1145","volume":"39","author":"R C\u00e9saire","year":"1999","unstructured":"C\u00e9saire R, Bera O, Maier H, Lezin A, Martial J, Ouka M, et al. Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique. French West Indies Transfusion. 1999;39(10):1145\u20139.","journal-title":"French West Indies Transfusion"},{"issue":"1","key":"534_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2011.05.022","volume":"52","author":"A Waters","year":"2011","unstructured":"Waters A, Oliveira AL, Coughlan S, de Venecia C, Schor D, Leite AC, et al. Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: addressing the issue of indeterminate HTLV results. J Clin Virol. 2011;52(1):38\u201344.","journal-title":"J Clin Virol"},{"issue":"3","key":"534_CR18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/314923","volume":"180","author":"SS Soldan","year":"1999","unstructured":"Soldan SS, Graf MD, Waziri A, Flerlage AN, Robinson SM, Kawanishi T, et al. HTLV-I\/II seroindeterminate western blot reactivity in a cohort of patients with neurological disease. J Infect Dis. 1999;180(3):685\u201394.","journal-title":"J Infect Dis"},{"issue":"13","key":"534_CR19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3109\/14767058.2013.852175","volume":"27","author":"S Suzuki","year":"2014","unstructured":"Suzuki S, Tanaka M, Matsuda H, Tsukahara Y, Kuribayashi Y, Gomibuchi H, et al. Instruction of feeding methods to Japanese pregnant women who cannot be confirmed as HTLV-1 carrier by western blot test. J Matern Fetal Neonatal Med. 2014;27(13):1392\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"534_CR20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/INF.0b013e31827efc39","volume":"32","author":"H Moriuchi","year":"2013","unstructured":"Moriuchi H, Masuzaki H, Doi H, Katamine S. Mother-to-child transmission of human T-cell lymphotropic virus type 1. Pediatr Infect Dis J. 2013;32(2):175\u20137.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"534_CR21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1128\/JCM.37.5.1324-1328.1999","volume":"37","author":"EC Sabino","year":"1999","unstructured":"Sabino EC, Zrein M, Taborda CP, Otani MM, Ribeiro-Dos-Santos G, S\u00e1ez-Alqu\u00e9zar A. Evaluation of the INNO-LIA HTLV I\/II assay for confirmation of human T-cell leukemia virus-reactive sera in blood bank donations. J Clin Microbiol. 1999;37(5):1324\u20138.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"534_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/CDLI.5.1.45-49.1998","volume":"5","author":"M Zrein","year":"1998","unstructured":"Zrein M, Louwagie J, Boeykens H, Govers L, Hendrickx G, Bosman F, et al. Assessment of a new immunoassay for serological confirmation and discrimination of human T-cell lymphotropic virus infections. Clin Diagn Lab Immunol. 1998;5(1):45\u20139.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"534_CR23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1537-2995.2002.00114.x","volume":"42","author":"R Thorstensson","year":"2002","unstructured":"Thorstensson R, Albert J, Andersson S. Strategies for diagnosis of HTLV-I and -II. Transfusion. 2002;42(6):780\u201391.","journal-title":"Transfusion"},{"issue":"5","key":"534_CR24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/aid.2014.0287","volume":"31","author":"A Caterino-de-Araujo","year":"2015","unstructured":"Caterino-de-Araujo A, Sacchi CT, Gon\u00e7alves MG, Campos KR, Magri MC, Alencar WK. Short Communication: current prevalence and risk factors associated with human T lymphotropic virus type 1 and human T lymphotropic virus type 2 infections among HIV\/AIDS patients in S\u00e3o Paulo Brazil. AIDS Res Hum Retroviruses. 2015;31(5):543\u20139.","journal-title":"AIDS Res Hum Retroviruses."},{"key":"534_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.01384-19","volume":"58","author":"KR Campos","year":"2019","unstructured":"Campos KR, Santos FLN, da Silva Brito V, Gon\u00e7alves NLS, Araujo THA, Galv\u00e3o-Castro B, et al. Line immunoassay for confirmation and discrimination of human T-cell lymphotropic virus infections in inconclusive western blot serum samples from Brazil. J Clin Microbiol. 2019;58:1.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"534_CR26","first-page":"227","volume":"63","author":"K Umeki","year":"2017","unstructured":"Umeki K, Umekita K, Hashikura Y, Yamamoto I, Kubo K, Nagatomo Y, et al. Evaluation of line immunoassay to detect HTLV-1 infection in an endemic area, Southwestern Japan; Comparison with polymerase chain reaction and western blot. Clin Lab. 2017;63(2):227\u201333.","journal-title":"Clin Lab"},{"issue":"2","key":"534_CR27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/JCM.02254-14","volume":"53","author":"M Kuramitsu","year":"2015","unstructured":"Kuramitsu M, Okuma K, Yamagishi M, Yamochi T, Firouzi S, Momose H, et al. Identification of TL-Om1, an adult T-cell leukemia (ATL) cell line, as reference material for quantitative PCR for human T-lymphotropic virus 1. J Clin Microbiol. 2015;53(2):587\u201396.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"534_CR28","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/JCM.01628-15","volume":"53","author":"M Kuramitsu","year":"2015","unstructured":"Kuramitsu M, Okuma K, Yamochi T, Sato T, Sasaki D, Hasegawa H, et al. Standardization of quantitative PCR for human T-cell leukemia virus type 1 in Japan: a collaborative study. J Clin Microbiol. 2015;53(11):3485\u201391.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"534_CR29","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/JCM.00659-17","volume":"55","author":"M Kuramitsu","year":"2017","unstructured":"Kuramitsu M, Sekizuka T, Yamochi T, Firouzi S, Sato T, Umeki K, et al. Proviral features of human T cell leukemia virus type 1 in carriers with indeterminate western blot analysis results. J Clin Microbiol. 2017;55(9):2838\u201349.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"534_CR30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/1348-0421.12644","volume":"62","author":"M Kuramitsu","year":"2018","unstructured":"Kuramitsu M, Okuma K, Nakashima M, Sato T, Sasaki D, Hasegawa H, et al. Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan. Microbiol Immunol. 2018;62(10):673\u20136.","journal-title":"Microbiol Immunol"},{"issue":"2","key":"534_CR31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1086\/514071","volume":"176","author":"P Maucl\u00e8re","year":"1997","unstructured":"Maucl\u00e8re P, Le Hesran JY, Mahieux R, Salla R, Mfoupouendoun J, Abada ET, et al. Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate western blots in Central Africa. J Infect Dis. 1997;176(2):505\u20139.","journal-title":"J Infect Dis"},{"issue":"4","key":"534_CR32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood.V77.4.896.896","volume":"77","author":"A Manns","year":"1991","unstructured":"Manns A, Murphy EL, Wilks R, Haynes G, Figueroa JP, Hanchard B, et al. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood. 1991;77(4):896\u2013905.","journal-title":"Blood"},{"issue":"3","key":"534_CR33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcv.2008.12.015","volume":"44","author":"JM Costa","year":"2009","unstructured":"Costa JM, Segurado AC. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from S\u00e3o Paulo. Brazil J Clin Virol. 2009;44(3):185\u20139.","journal-title":"Brazil J Clin Virol"},{"issue":"11","key":"534_CR34","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1349-7006.2010.01720.x","volume":"101","author":"S Kamihira","year":"2010","unstructured":"Kamihira S, Yamano Y, Iwanaga M, Sasaki D, Satake M, Okayama A, et al. Intra- and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: a multi-center study. Cancer Sci. 2010;101(11):2361\u20137.","journal-title":"Cancer Sci"},{"issue":"2","key":"534_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/aid.2010.0017","volume":"27","author":"DS Zanjani","year":"2011","unstructured":"Zanjani DS, Shahabi M, Talaei N, Afzalaghaee M, Tehranian F, Bazargani R. Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1\/2) seroindeterminate blood donors from Northeast Iran: evidence of proviral tax, env, and gag sequences. AIDS Res Hum Retroviruses. 2011;27(2):131\u20135.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"534_CR36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"issue":"2","key":"534_CR37","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/jvi.66.2.906-913.1992","volume":"66","author":"C Pique","year":"1992","unstructured":"Pique C, Pham D, Tursz T, Dokh\u00e9lar MC. Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation. J Virol. 1992;66(2):906\u201313.","journal-title":"J Virol"},{"issue":"1","key":"534_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.2001.5821","volume":"289","author":"M Hern\u00e1ndez Marin","year":"2001","unstructured":"Hern\u00e1ndez Marin M, Castellanos Pent\u00f3n P, M\u00e1rquez Bocalandro Y, Pozo Pe\u00f1a L, D\u00edaz Navarro J, Gonz\u00e1lez L\u00f3pez LJ. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus. Biochem Biophys Res Commun. 2001;289(1):1\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"534_CR39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ana.410330411","volume":"33","author":"S Jacobson","year":"1993","unstructured":"Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy\/tropical spastic paraparesis. Ann Neurol. 1993;33(4):392\u20136.","journal-title":"Ann Neurol"},{"issue":"11","key":"534_CR40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/1348-0421.12740","volume":"63","author":"M Kuramitsu","year":"2019","unstructured":"Kuramitsu M, Okuma K, Tezuka K, Nakamura H, Sagara Y, Kurane I, et al. Development and evaluation of human T-cell leukemia virus-1 and -2 multiplex quantitative PCR. Microbiol Immunol. 2019;63(11):458\u201364.","journal-title":"Microbiol Immunol"},{"key":"534_CR41","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Use of serological tests to reduce the risk of transfusion-transmitted human T-lymphotropic virus types I and II (HTLV-I\/II): guidance for industry, 2020."},{"issue":"3","key":"534_CR42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jmv.21083","volume":"80","author":"X Qiu","year":"2008","unstructured":"Qiu X, Hodges S, Lukaszewska T, Hino S, Arai H, Yamaguchi J, et al. Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies. J Med Virol. 2008;80(3):484\u201393.","journal-title":"J Med Virol"},{"issue":"6","key":"534_CR43","doi-asserted-by":"crossref","first-page":"e22909","DOI":"10.1002\/jcla.22909","volume":"33","author":"SG Yun","year":"2019","unstructured":"Yun SG, Kim SW, Sohn JY, Cho Y. Evaluation of Elecsys HTLV-I\/II assay in comparison with ARCHITECT rHTLV-I\/II assay with Korean samples. J Clin Lab Anal. 2019;33(6):e22909.","journal-title":"J Clin Lab Anal"},{"issue":"7","key":"534_CR44","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood-2004-09-3646","volume":"106","author":"M Watanabe","year":"2005","unstructured":"Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood. 2005;106(7):2462\u201371.","journal-title":"Blood"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-020-00534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12977-020-00534-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-020-00534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T06:29:55Z","timestamp":1696573795000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-020-00534-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1186\/s12977-020-00534-0","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethical review boards at the National Institute of Infectious Diseases (Tokyo, Japan) (IRB approval No. 837). This study was also conducted according to the principles in the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}